Clariant, a focused and innovative specialty chemical company, today announced the completion of the sale of its Healthcare Packaging business to a newly-formed investment of Arsenal Capital Partners, the signing of which was announced on July 22, 2019. The sale was closed on October 31, 2019.
“The divestment of the Healthcare Packaging business is the first step of our announced strategy to become a more focused and innovative specialty chemical company,” said Hariolf Kottmann, Executive Chairman of Clariant.
The total consideration of the sale amounts to approximately CHF 308 million which is equivalent to 13.2 times adjusted FY 2018 EBITDA.
